474 related articles for article (PubMed ID: 18448867)
1. Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice.
Morita K; Motoyama N; Kitayama T; Morioka N; Kifune K; Dohi T
J Pharmacol Exp Ther; 2008 Aug; 326(2):633-45. PubMed ID: 18448867
[TBL] [Abstract][Full Text] [Related]
2. Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain.
Dohi T; Morita K; Kitayama T; Motoyama N; Morioka N
Pharmacol Ther; 2009 Jul; 123(1):54-79. PubMed ID: 19393690
[TBL] [Abstract][Full Text] [Related]
3. Long-term application of glycine transporter inhibitors acts antineuropathic and modulates spinal N-methyl-D-aspartate receptor subunit NR-1 expression in rats.
Barthel F; Urban A; Schlösser L; Eulenburg V; Werdehausen R; Brandenburger T; Aragon C; Bauer I; Hermanns H
Anesthesiology; 2014 Jul; 121(1):160-9. PubMed ID: 24598217
[TBL] [Abstract][Full Text] [Related]
4. Glycine transporter inhibitors as a potential therapeutic strategy for chronic pain with memory impairment.
Tanabe M; Takasu K; Yamaguchi S; Kodama D; Ono H
Anesthesiology; 2008 May; 108(5):929-37. PubMed ID: 18431130
[TBL] [Abstract][Full Text] [Related]
5. Loss of spinal glycinergic neurons is not necessary for development of neuropathic pain in transgenic mice expressing enhanced green fluorescent protein in glycinergic neurons.
Hermanns H; Muth-Selbach U; Lipfert P; Braun S; Werdehausen R; Bauer I
Neuroscience; 2009 Mar; 159(3):1148-53. PubMed ID: 19356695
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive effect of intracerebroventricular administration of glycine transporter-2 inhibitor ALX1393 in rat models of inflammatory and neuropathic pain.
Takahashi Y; Hara K; Haranishi Y; Terada T; Obara G; Sata T
Pharmacol Biochem Behav; 2015 Mar; 130():46-52. PubMed ID: 25579325
[TBL] [Abstract][Full Text] [Related]
7. Activation of extracellular signal-regulated kinase in sciatic nerve contributes to neuropathic pain after partial sciatic nerve ligation in mice.
Kiguchi N; Maeda T; Kobayashi Y; Fukazawa Y; Kishioka S
Anesth Analg; 2009 Oct; 109(4):1305-11. PubMed ID: 19762761
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of spinally applied glycine transporter inhibitors on nociception in a rat model of neuropathic pain.
Hermanns H; Muth-Selbach U; Williams R; Krug S; Lipfert P; Werdehausen R; Braun S; Bauer I
Neurosci Lett; 2008 Nov; 445(3):214-9. PubMed ID: 18793697
[TBL] [Abstract][Full Text] [Related]
9. Glycine transporter GlyT1, but not GlyT2, is expressed in rat dorsal root ganglion--Possible implications for neuropathic pain.
Schlösser L; Barthel F; Brandenburger T; Neumann E; Bauer I; Eulenburg V; Werdehausen R; Hermanns H
Neurosci Lett; 2015 Jul; 600():213-9. PubMed ID: 26101830
[TBL] [Abstract][Full Text] [Related]
10. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.
Bordet T; Buisson B; Michaud M; Abitbol JL; Marchand F; Grist J; Andriambeloson E; Malcangio M; Pruss RM
J Pharmacol Exp Ther; 2008 Aug; 326(2):623-32. PubMed ID: 18492948
[TBL] [Abstract][Full Text] [Related]
11. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A.
Quartaroli M; Carignani C; Dal Forno G; Mugnaini M; Ugolini A; Arban R; Bettelini L; Maraia G; Belardetti F; Reggiani A; Trist DG; Ratti E; Di Fabio R; Corsi M
J Pharmacol Exp Ther; 1999 Jul; 290(1):158-69. PubMed ID: 10381772
[TBL] [Abstract][Full Text] [Related]
12. Glycine transporter inhibitors: A new avenue for managing neuropathic pain.
Al-Khrasani M; Mohammadzadeh A; Balogh M; Király K; Barsi S; Hajnal B; Köles L; Zádori ZS; Harsing LG
Brain Res Bull; 2019 Oct; 152():143-158. PubMed ID: 31302238
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of [(3)H]glycine release from mouse spinal cord synaptosomes selectively labeled through GLYT2 transporters.
Luccini E; Raiteri L
J Neurochem; 2007 Dec; 103(6):2439-48. PubMed ID: 17944872
[TBL] [Abstract][Full Text] [Related]
14. The antinociceptive effect of intrathecal administration of glycine transporter-2 inhibitor ALX1393 in a rat acute pain model.
Haranishi Y; Hara K; Terada T; Nakamura S; Sata T
Anesth Analg; 2010 Feb; 110(2):615-21. PubMed ID: 20081141
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of the GABA-transporter GAT-1 in the spinal cord contributes to pain behaviour in experimental neuropathy.
Daemen MA; Hoogland G; Cijntje JM; Spincemaille GH
Neurosci Lett; 2008 Oct; 444(1):112-5. PubMed ID: 18694804
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
[TBL] [Abstract][Full Text] [Related]
17. Spinal astrocytic activation contributes to mechanical allodynia in a mouse model of type 2 diabetes.
Liao YH; Zhang GH; Jia D; Wang P; Qian NS; He F; Zeng XT; He Y; Yang YL; Cao DY; Zhang Y; Wang DS; Tao KS; Gao CJ; Dou KF
Brain Res; 2011 Jan; 1368():324-35. PubMed ID: 20971097
[TBL] [Abstract][Full Text] [Related]
18. PPADS, a purinergic antagonist reduces Fos expression at spinal cord level in a mouse model of mononeuropathy.
Borsani E; Albertini R; Colleoni M; Sacerdote P; Trovato AE; Lonati C; Labanca M; Panerai AE; Rezzani R; Rodella LF
Brain Res; 2008 Mar; 1199():74-81. PubMed ID: 18302958
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain.
Toth CC; Jedrzejewski NM; Ellis CL; Frey WH
Mol Pain; 2010 Mar; 6():16. PubMed ID: 20236533
[TBL] [Abstract][Full Text] [Related]
20. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain.
Holdridge SV; Cahill CM
Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
